Sort
82,697 grants matching “vaccine development”
HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection
$678,045Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AI
HPV-related Oropharyngeal Cancer Screening and Monitoring through Remote Self-Sampling
$678,031Erich M Sturgis · Baylor College Of Medicine · U01 · FY2025 · DE
Emergence, Progression and Impact of SARS-CoV-2 Variants in West Virginia
$678,030Sally Lynn Hodder · West Virginia University · U54 · FY2021 · GM
Development of Vaccines for Chikungunya and Other Alphaviruses
$678,000Srinivas Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Development of Vaccines for Chikungunya and Other Alphaviruses
$678,000Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Development of Vaccines for Chikungunya and Other Alphaviruses
$678,000Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Development of Vaccines for Chikungunya and Other Alphaviruses
$678,000Srinivas Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Development of Vaccines for Chikungunya and Other Alphaviruses
$678,000Srinivas Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy
$677,986Lisa A. Cavacini · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Live-attenuated Rift Valley fever vaccines: comparative mechanisms of trans-placental transmission and vaccine efficacy for developing fetuses
$677,858Amy L Hartman · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Mechanistic and functional dissection of inflammaging in Down syndrome
$677,851Bernard Khor · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · AI
Mechanistic and functional dissection of inflammaging in Down syndrome
$677,851Bernard Khor · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · AI
Mechanistic and functional dissection of inflammaging in Down syndrome
$677,851Bernard Khor · Benaroya Research Inst At Virginia Mason · R01 · FY2025 · AI
Mechanistic and functional dissection of inflammaging in Down syndrome
$677,851Bernard Khor · Benaroya Research Inst At Virginia Mason · R01 · FY2023 · AI
Project 2: Durable impact of HCV on innate and adaptive immunity
$677,806Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2025 · AI
Vaccine immunity and inflammation in the aging person living with HIV
$677,777Anne Elizabeth Parker Frosch · Hennepin Healthcare Research Institute · R01 · FY2024 · AG
An inoculation theory-based messaging intervention addressing misinformation about HPV vaccine on social media: The Inoculate for HPV Vaccine randomized controlled trial
$677,727Melanie Lynn Kornides · University Of Pennsylvania · R37 · FY2022 · CA
The role of enteric pathogens and antimicrobial resistance in driving clinical and nutritional deterioration, and azithromycin's potential effect, among children discharged from hospital in Kenya
$677,721Patricia Pavlinac · University Of Washington · R01 · FY2022 · AI
Role of Host Protein Kinase C in Cryptosporidiosis
$677,703Chelsea S. Marie · University Of Virginia · R01 · FY2023 · AI
Salmonella-specific therapeutics
$677,686Brian M Ahmer · Ohio State University · R01 · FY2020 · AI
Adoptive transfer of immunity elicited by attenuated HIV vaccines
$677,672David H Oconnor · University Of Wisconsin-Madison · R01 · FY2008 · AI
Molecular Genetics of Dengue Resistance in Mosquitoes
$677,633University Of Notre Dame · R01 · FY2004 · AI
Lymphoma Studies
$677,573Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN
$677,450Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2012 · AI
Pediatric Respiratory Illness Measurement System (PRIMES) Implementation in Community Hospital Settings
$677,449Rita Mangione-Smith · Kaiser Foundation Research Institute · R01 · FY2025 · HL